Brigola, Sestan Khart Q.

HRN: 23-00-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2024
CEFUROXIME 750MG (VIAL)
11/24/2024
12/01/2024
IV
550mg
Q8H
UTI
Waiting Final Action 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes